An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path Initiative.
暂无分享,去创建一个
Weida Tong | Leming Shi | Hong Fang | Roger Perkins | Felix W Frueh | Stephen C Harris | Federico Goodsaid | Stephen C. Harris | Leming Shi | W. Tong | F. Frueh | H. Fang | R. Perkins | F. Goodsaid
[1] Hanlee P. Ji,et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.
[2] Weida Tong,et al. Development of public toxicogenomics software for microarray data management and analysis. , 2004, Mutation research.
[3] Felix W Frueh,et al. Impact of microarray data quality on genomic data submissions to the FDA , 2006, Nature Biotechnology.
[4] Stephen C. Harris,et al. ArrayTrack - Supporting Toxicogenomic Research at the FDA?s National Center for Toxicological Research (NCTR) , 2003 .
[5] Weida Tong,et al. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. , 2003, Environmental health perspectives.
[6] Tao Chen,et al. GOFFA: Gene Ontology For Functional Analysis – A FDA Gene Ontology Tool for Analysis of Genomic and Proteomic Data , 2006, BMC Bioinformatics.